Jeff Liter

• Understanding the key phenotypic traits that define an ideal Gamma-Delta T-cell donor for therapeutic use
• Learning how a structured screening strategy is used to characterize and select top-performing donors
• Exploring how donor variability impacts cell expansion and potency, informing better CAR-T development

An interactive panel discussion from the industry leaders in the field to set the scene on the donor space. Ask your questions live to understand the expert’s thoughts on key topics including:

• Reviewing the current use of donor-derived material and the impacts of donor-based variability
• Navigating the trade-offs between efficient donor selection and consistent product quality
• Enhancing donor screening approaches to minimize variability and improve yield